NIH, BARDA award $98.35M in COVID-19 testing contracts

By staff writers

October 7, 2020 -- The U.S. National Institutes of Health (NIH), along with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal health agency, has awarded $98.35 million in contracts for COVID-19 testing under the Rapid Acceleration of Diagnostics (RADx) initiative.

The following companies were awarded contracts to scale up and manufacture tests under the new RADx awards:

  • California-based Luminostics' clip COVID rapid antigen test uses glow-in-the-dark nanomaterials to detect SARS-CoV-2 from shallow nasal swabs in no more than 30 minutes.
  • New Zealand-based Ubiquitome's Liberty16 battery-operated reverse transcription polymerase chain reaction (RT-PCR) device detects viral RNA with high accuracy in 40 minutes and reports results via a smartphone app.
  • California-based Ellume's two test cartridges contain a single-use, digital fluorescent immunoassay antigen test that returns accurate results within 15 minutes or less. One cartridge will be used for point-of-care or laboratory testing, and the other will be for at-home testing.
  • Massachusetts-based Quanterix's lab antigen test with single-molecule immunoassay technology enables detection from nasopharyngeal, saliva, or self-acquired blood samples.
  • Wisconsin-based Flambeau Diagnostics developed a lab module that can be deployed in a mobile van and can screen asymptomatic individuals for SARS-CoV-2 at low viral levels in saliva samples. Results are returned within an hour.
  • California-based Visby Medical created a palm-sized, single-use RT-PCR device that detects viral RNA at the point of care in 30 minutes.
NIH to spend $129M to scale up COVID-19 testing
The U.S. National Institutes of Health (NIH) plans to spend about $129 million to scale up COVID-19 testing capacity and provide manufacturing support....
NIH establishes Centers for Research in Emerging Infectious Diseases
The National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH), has awarded 11 grants for a first-year...
Firm developing rapid gonorrhea test wins $19M prize
A company developing a rapid diagnostic test for the microorganism that causes gonorrhea has won $19 million in a challenge that's part of the U.S....
NIH invests almost $249M in 7 COVID-19 test technologies
The U.S. National Institutes of Health (NIH) is touting the results of its "Shark Tank" approach to spurring development in COVID-19 testing technologies,...
Ortho to develop SARS-CoV-2 antibody test with BARDA funds
Ortho Clinical Diagnostics is developing a high-specificity SARS-CoV-2 antibody test with $678K in funding from the Biomedical Advanced Research and Development...

Copyright © 2020

Last Updated np 10/12/2020 5:10:27 PM

Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current